News

Viyash Scientific announced that the 41th Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27. The transaction represents a significant step in Viyash`s strategy to capitalize on the mega-trend of a growing Companion Animal Health Generics market. It expands Alivira`s global Companion Animal Health business and strengthens its presence in the European pet care market.

Net profit of Viyash Scientific rose 459.12% to Rs 52.11 crore in the quarter ended March 2026 as against Rs 9.32 crore during the previous quarter ended March 2025. Sales rose 129.02% to Rs 919.96 crore in the quarter ended March 2026 as against Rs 401.70 crore during the previous quarter ended March 2025.For the full year,net profit rose 663.48% to Rs 177.28 crore in the year ended March 2026 as against Rs 23.22 crore during the previous year ended March 2025. Sales rose 13.75% to Rs 3420.31 crore in the year ended March 2026 as against Rs 3006.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales919.96401.70 129 3420.313006.84 14 OPM %20.0311.51 -19.0812.87 - PBDT185.6532.77 467 626.87333.45 88 PBT125.2416.65 652 393.2394.74 315 NP52.119.32 459 177.2823.22 663 Powered by Capital Market - Live News

Viyash Scientific will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Net profit of Viyash Scientific declined 13.83% to Rs 38.44 crore in the quarter ended December 2025 as against Rs 44.61 crore during the previous quarter ended December 2024. Sales rose 10.90% to Rs 858.41 crore in the quarter ended December 2025 as against Rs 774.03 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales858.41774.03 11 OPM %20.4612.89 - PBDT172.8685.76 102 PBT114.3327.37 318 NP38.4444.61 -14 Powered by Capital Market - Live News